Skip to main content
SpringerLink
Log in

Membrane glycoprotein PC-1 and insulin resistance

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Peripheral resistance to insulin is a major component of non-insulin dependent diabetes mellitus. Defects in insulin receptor tyrosine kinase activity have been demonstrated in several tissues from insulin resistant subjects, but mutations in the insulin receptor gene occur in only a small fraction of cases. Therefore, other molecules that are capable of modulating the function of the insulin receptor are likely candidates in the search for the cellular mechanisms of insulin resistance. We have isolated an inhibitor of insulin receptor tyrosine kinase activity from cultured fibroblasts of an insulin resistant NIDDM patient and identified it as membrane glycoprotein PC-1. Subsequently we have demonstrated that expression of PC-1 is elevated in fibroblasts from other insulin resistant subjects, both with and without NIDDM. Studies in muscle, the primary site for insulin-mediated glucose disposal, have shown that the levels of PC-1 in this tissue are inversely correlated to insulin action both in vivo and in vitro. Transfection of PC-1 into cultured cells has confirmed that overexpression of PC-1 can produce impairments in insulin receptor tyrosine kinase activity and the subsequent cellular responses to insulin. Preliminary data suggests a direct interaction between PC-1 and the insulin receptor. However, the mechanisms whereby PC-1 inhibits insulin receptor signaling remain to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37: 1595–607, 1988

    PubMed  Google Scholar 

  2. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066–1084, 1994

    PubMed  Google Scholar 

  3. Kruszynska YT, Olefsky JM: Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Invest Med 44: 423–428, 1996

    Google Scholar 

  4. Hamman RF: Genetic and environmental determinants of non-insulin-dependent-diabetes mellitus (NIDDM). Diabet/Metabol Rev 8: 287–338, 1992

    Google Scholar 

  5. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and crosssectional studies in Pima Indians. N Engl J Med 318: 1217–1225, 1988

    PubMed  Google Scholar 

  6. Martin BC, Warrarn JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 340: 925–929, 1992

    PubMed  Google Scholar 

  7. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Puente AE-D, Knowler WC, Ravussin ER, Mott DM, Bennett PH: Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 38: 1423–1432, 1989

    PubMed  Google Scholar 

  8. Lillioja S, Mott DM, Zawadzki KK, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is a familial characteristic in nondiabetic Pima Indians. Diabetes 36: 1329–1335, 1987

    PubMed  Google Scholar 

  9. Vaag A, Henriksen JE, Maclsbad S, Holm N, Beck-Nielsen H: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95: 690–698, 1995

    PubMed  Google Scholar 

  10. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven GM: Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248: E286–E291, 1985

    PubMed  Google Scholar 

  11. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky JM: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44: 1121–1125, 1995

    PubMed  Google Scholar 

  12. Brindley DN: Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes Rel Metabol Disorders 19(suppl 1): S69–S75, 1995

    Google Scholar 

  13. Moller N, Jorgensen JD, Moller J, Orskov L, Ovesen P, Schmitz 0, Christiansen JS, Orskov H: Metabolic effects of growth hormone in humans. Metabol Clin Exp 44(suppl 4): 33–36, 1995

    Google Scholar 

  14. DeMeyts P: The structural basis of insulin and insulin-like growth factor-1 receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signaling. Diabetologia 37 (Suppl 2): S135–S148, 1994

    PubMed  Google Scholar 

  15. Goldfine ID: The insulin receptor: Molecular biology and transmembrane signalling. Endocr Rev 8: 235–255, 1987

    PubMed  Google Scholar 

  16. Kahn CR, White MF: The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82: 1151–1156, 1988

    PubMed  Google Scholar 

  17. White MF: The IRS-1 signaling system. Curr Opin Genet Devel 4: 47–54, 1994

    Google Scholar 

  18. Moller DE, Flier JS: Insulin resistance – mechanisms, syndromes, and implications. New Eng J Med 325: 938–948, 1991

    PubMed  Google Scholar 

  19. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337, 1987

    PubMed  Google Scholar 

  20. Grasso G, Frittitta L, Anello M, Russo P, Susti G, Trischitta V: Insulin receptor tyrosine kinase activity is altered in both muscle and adipose tissue from nonobese normoglycemic insulin resistant subjects. Diabetologia 38: 55–61, 1995

    PubMed  Google Scholar 

  21. Handberg A, Vaag A, Vinten J, Beck-Nielsen H: Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, nonobese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 668–674, 1993

    PubMed  Google Scholar 

  22. Dunaif A, Xia J, Book C-B, Schenker E, Tang Z Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the Polycystic Ovary Syndrome. J Clin Invest 96: 801–810, 1995

    PubMed  Google Scholar 

  23. Taylor SI: Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41: 1473–1490, 1992

    PubMed  Google Scholar 

  24. Yano T, Funakoshi I, Yamashina I: Purification and properties of nucleotide pyrophosphatase. J Biochem 98: 1097–1107, 1985

    PubMed  Google Scholar 

  25. van Driel IR, Goding JW: Plasma cell membrane glycoprotein PC-1. J Biol Chem 262: 4882–4887, 1987

    PubMed  Google Scholar 

  26. Harahap AR, Goding M Distribution of PC-1 in non lymphoid tissues. J Immunol 141: 2317–2320, 1988

    PubMed  Google Scholar 

  27. Buckley MF, Loveland KA, McKinstry WJ, Garson OM, Goding JW: Plasma cell membrane glycoprotein PC-1 cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. J Biol Chem 265: 17506–17511, 1990

    PubMed  Google Scholar 

  28. Rebbe NF, Tong BD, Finley EM, Hickman S: Identification of nucleotide pyrophosphatase/alkaline phosphodiesterase I activity associated with the mouse plasma cell differentiation antigen PC-1. Proc Natl Acad Sci USA 88: 5192–5196, 1991

    PubMed  Google Scholar 

  29. Funakoshi I, Kato H, Horie K, Yano T, Hori Y, Kobayashi H, Inoue T, Suzuki H, Fukui S, Tsukahara M, Kajii T, Yamashina I: Molecular cloning of human nucleotide pyrophosphatase. Arch Biochem Biophys 295: 180–187, 1992

    PubMed  Google Scholar 

  30. Uriarte M, Stalmans W, Hickman S, Bollen M: Phosphorylation and nucleotide-dependent dephosphorylation of hepatic polypeptides related to the plasma cell differentiation antigen PC-1. Biochem J 293: 93–100, 1993

    PubMed  Google Scholar 

  31. Rebbe NF, Tong BID, Hickman S: Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 30: 87–93, 1993

    PubMed  Google Scholar 

  32. Yoshida H, Fukui S, Funakoshi I, Yamashina I: Substrate specificity of a nucleotide pyrophosphatase responsible for the breakdown of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) from human placenta. J Biochem 93: 1641–1648, 1983

    PubMed  Google Scholar 

  33. Kawagoe H, Soma 0, Goji J, Nishimura N, Narita M, Inazawa J, Nakamura H, Sano K: Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/Nucleotide Pyrophosphotase Gene (PDNP2). Genomics 30: 380–384, 1995

    PubMed  Google Scholar 

  34. Murata J, Lee HY, Clair T, Krutzsch HC, Arestad AA, Sobel ME, Liotta LA, Stracke M: cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterase. J Biol Chem 269: 30479–30484, 1994

    PubMed  Google Scholar 

  35. Deisler H, Lottspeich F, Rajewsky MF: Affinity purification and cDNA cloning of rat neural differentiation and tumor cell surface antigen gp130 RB13–6 reveals relationship to human and murine PC-1. J Biol Chem 270: 9849–9855, 1995

    PubMed  Google Scholar 

  36. Youngren J, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID: Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes 45: 1324–1328, 1996

    PubMed  Google Scholar 

  37. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R Goldfine ID, Trischitta V: Increased adipose tissue PC-1 protein content but not TNF-α gene expression is associated to a reduction in whole body insulin sensitivity and insulin receptor tyrosine kinase activity. Diabetologia, March 1997, (in press)

  38. Belli AI, van Driel IR, Goding JW: Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase) Endo J Biochem 217: 421–428, 1993

    Google Scholar 

  39. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart T: Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of Adenosine triphosphate or the generation of Adenosine. J Biol Chem 270: 22085–22088, 1995

    PubMed  Google Scholar 

  40. Oda Y, Kuo M-D, Huang SS, Huang JS The plasma cell membrane glycoprotein, PC-1, is a threonine specific protein kinase stimulated by acidic fibroblast growth factor. J Biol Chem 266: 16791–16795, 1991

    PubMed  Google Scholar 

  41. Stern MP, Duggurila R, Mitchell BD, Reinhart U, Shivakumar S, Shipman PA, Uresandi OC, Benavides E, Blangero J, O'Connell P: Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans. Genome Res 6: 724–734, 1996

    PubMed  Google Scholar 

  42. Temple IK, Gardner RJ, Robinson DO, Kilbirige MS, Ferguson AW, Baum JD, Barber JCK, James RS, Shield JPH: Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Human Mol Genet 5: 1117–1121, 1996

    Google Scholar 

  43. von Muhlendahl KE, Herkennoff H: Longterm course of neonatal diabetes. New Engl J Med 333: 704–708, 1995

    PubMed  Google Scholar 

  44. Doria A, Federman S, Rich SS, Warram JH, Krolewski AS: DNA polymorphisms and mapping on chromosome 6q of plasma-cell antigen 1 (PC-1), an insulin signal inhibitor. Diabetologia 39(suppl 1): A77, 1996

    Google Scholar 

  45. Sbraccia P, Goodman PA, Maddux BA, Chen Y-DI, Reaven GM, Goldfine ID: Production of an inhibitor of insulin receptor tyrosine kinase in fibroblasts from a patient with insulin resistance and NIDDM. Diabetes 40: 295–299, 1991

    PubMed  Google Scholar 

  46. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID: Membrane Glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes. Nature 373: 448–451, 1995

    PubMed  Google Scholar 

  47. Whitehead JP, Humphreys PJ, Maasen JA, Moller DE, Krook A, O'Rahilly S: Increased PC-1 phosphodieste rase activity in patients with postreceptor insulin resistance but not in patients with insulin receptor mutations. Diabetologia [Suppl 1]: I–V, A65, 1995

    Google Scholar 

  48. Bonadonna RC, De Fronzo RA: Glucose metabolism in obesity and type 2 diabetes. Diabet Metab 17: 112–135, 1991

    Google Scholar 

  49. Frittitta L, Youngren J, Trischitta V, Goldfine ID: Membrane glycoprotein PC-1 content in skeletal muscle of non obese, non diabetic subjects: Relationship to insulin receptor tyrosine kinase activity and whole body insulin sensitivity. Diabetologia 39: 1190–1195, 1996

    PubMed  Google Scholar 

  50. Reaven GM: The fourth musketeer, from Alexander Dumas to Claude Bernard. Diabetologia 38: 3–13, 1995

    PubMed  Google Scholar 

  51. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R Goldfine ID, Belfiore A: Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52: 3924–3930, 1992

    PubMed  Google Scholar 

  52. Osborne CK, Monaco ME, Lippmann ME: Hormone responsive human breast cancer in long-term tissue culture: Effect on insulin. Proc Natl Acad Sci USA 73(12): 4536–4540, 1976

    PubMed  Google Scholar 

  53. Ebina Y, Ellis L, Jamagin K, Edery M, Graf L, Clauser E, Ou J-H, Maslarz F, Kan YW, Goldfine ID, Roth RA, Rutter WJ: The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling. Cell 40: 747–758, 1985

    PubMed  Google Scholar 

  54. Rousseau GG, Amar-Costesec A, Verhaegen M, Granner DK: Glucocorticoid hormones increase the activity of plasma membrane alkaline phosphodiesterase I in rat hepatoma cells. Proc Natl Acad Sci USA 77: 1005–1009, 1980

    PubMed  Google Scholar 

  55. Buckley MF, Goding JW: Plasma cell membrane glycoprotein gene PC-1 (alkaline phosphodiesterase 1) is linked to the proto-oncogene Myb on mouse chromosome 10. Immunogenetics 36: 199–201, 1992

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Diabetes and Endocrine Research, 1600 Divisadero Street, UCSF Box 1616, San Francisco, CA, 94143-1616, USA

    Ira D. Goldfine, Betty A. Maddux, Jack F. Youngren, Lucia Frittitta, Vincenzo Trischitta & G. Lynis Dohm

Authors
  1. Ira D. Goldfine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Betty A. Maddux
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jack F. Youngren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lucia Frittitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincenzo Trischitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Lynis Dohm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldfine, I.D., Maddux, B.A., Youngren, J.F. et al. Membrane glycoprotein PC-1 and insulin resistance. Mol Cell Biochem 182, 177–184 (1998). https://doi.org/10.1023/A:1006878001180

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006878001180

Search

Navigation